Capabase
A configurable corrective-and-preventive-action workspace for smaller regulated manufacturers, joining deviations, investigations, root-cause evidence, actions, training, effectiveness checks, signatures, and immutable audit history.
The QMSR transition, cited inspection findings, expensive established suites, and a closer SMB competitor validate demand. Capabase narrows the quality system to CAPA and rapid configuration, but one-day activation cannot establish a validated state, ISO alignment, or electronic-record compliance by itself. Its product is a controlled lifecycle with versioned procedures, attributable records, reviewer-owned conclusions, linked changes and training, overdue effectiveness checks, and a customer-specific validation package.
The quality, regulatory, or operations leader at a smaller medical-device or life-sciences manufacturer managing CAPA outside a suitable quality system.
The cited February 2026 transition creates current inspection and remediation pressure.
Quality leaders at smaller regulated manufacturers own an urgent CAPA workflow.
The idea has many internal links but moderate grounded convergence.
A current regulatory transition, clear quality buyer, costly incumbent, closer SMB validator, and focused CAPA workflow support the concept.
The market is occupied, validation and implementation remain customer-specific, regulated claims are demanding, and fast setup is not a durable moat.
Discussion
No comments yet — be the first to weigh in.